Sisram Medical Reports Stable Share Capital and Public Float Compliance for April 2026

Bulletin Express

May 06

Hong Kong, 6 May 2026 – Sisram Medical Ltd. released its Monthly Return for Equity Issuers, confirming that no changes occurred in authorised, issued or treasury shares during April 2026.

Authorised Share Capital • Authorised share count remained at 1.00 billion ordinary shares, each with a par value of ILS 0.01, keeping total authorised capital unchanged at ILS 10.00 million.

Issued Shares • Issued shares stood at 468.34 million, identical to the previous month. • The company held no treasury shares, leaving total issued shares unchanged at 468.34 million.

Public Float • Sisram Medical affirmed compliance with the Main Board’s Initial Prescribed Threshold, maintaining at least 25 % of issued shares in public hands as at 30 April 2026.

No activity was reported under share option schemes, warrants, convertibles or other share-related arrangements. The filing was signed by Company Secretary Qianli Fang.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1145616031"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1145616031\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1145616031?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145616031","market":"us","top_or_hot":-1,"title":"Sisram Medical Reports Stable Share Capital and Public Float Compliance for April 2026","media":"Bulletin Express","content":"<p>Hong Kong, 6 May 2026 – Sisram Medical Ltd. released its Monthly Return for Equity Issuers, confirming that no changes occurred in authorised, issued or treasury shares during April 2026.</p>\n<p>Authorised Share Capital  \n• Authorised share count remained at 1.00 billion ordinary shares, each with a par value of ILS 0.01, keeping total authorised capital unchanged at ILS 10.00 million.</p>\n<p>Issued Shares  \n• Issued shares stood at 468.34 million, identical to the previous month.  \n• The company held no treasury shares, leaving total issued shares unchanged at 468.34 million.</p>\n<p>Public Float  \n• Sisram Medical affirmed compliance with the Main Board’s Initial Prescribed Threshold, maintaining at least 25 % of issued shares in public hands as at 30 April 2026.</p>\n<p>No activity was reported under share option schemes, warrants, convertibles or other share-related arrangements. The filing was signed by Company Secretary Qianli Fang.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sisram Medical Reports Stable Share Capital and Public Float Compliance for April 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSisram Medical Reports Stable Share Capital and Public Float Compliance for April 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-06 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong, 6 May 2026 – Sisram Medical Ltd. released its Monthly Return for Equity Issuers, confirming that no changes occurred in authorised, issued or treasury shares during April 2026.</p>\n<p>Authorised Share Capital  \n• Authorised share count remained at 1.00 billion ordinary shares, each with a par value of ILS 0.01, keeping total authorised capital unchanged at ILS 10.00 million.</p>\n<p>Issued Shares  \n• Issued shares stood at 468.34 million, identical to the previous month.  \n• The company held no treasury shares, leaving total issued shares unchanged at 468.34 million.</p>\n<p>Public Float  \n• Sisram Medical affirmed compliance with the Main Board’s Initial Prescribed Threshold, maintaining at least 25 % of issued shares in public hands as at 30 April 2026.</p>\n<p>No activity was reported under share option schemes, warrants, convertibles or other share-related arrangements. The filing was signed by Company Secretary Qianli Fang.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01696","symbol_name":"复锐医疗科技","start_time":0,"source_url":"","article_id":"1145616031","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145616031","pubTimestamp":1778059394,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong, 6 May 2026 – Sisram Medical Ltd. released its Monthly Return for Equity Issuers, confirming that no changes occurred in authorised, issued or treasury shares during April 2026. Authorised...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01696":"复锐医疗科技"},"translate_title":"Sisram Medical报告2026年4月股本和公众持股量稳定","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01696":1},"content_text":"Hong Kong, 6 May 2026 – Sisram Medical Ltd. released its Monthly Return for Equity Issuers, confirming that no changes occurred in authorised, issued or treasury shares during April 2026.\nAuthorised Share Capital  \n• Authorised share count remained at 1.00 billion ordinary shares, each with a par value of ILS 0.01, keeping total authorised capital unchanged at ILS 10.00 million.\nIssued Shares  \n• Issued shares stood at 468.34 million, identical to the previous month.  \n• The company held no treasury shares, leaving total issued shares unchanged at 468.34 million.\nPublic Float  \n• Sisram Medical affirmed compliance with the Main Board’s Initial Prescribed Threshold, maintaining at least 25 % of issued shares in public hands as at 30 April 2026.\nNo activity was reported under share option schemes, warrants, convertibles or other share-related arrangements. The filing was signed by Company Secretary Qianli Fang.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}